Relationship Between Amyloid-β Deposition and Blood–Brain Barrier Dysfunction in Alzheimer’s Disease
Amyloid-β (Aβ) is the predominant pathologic protein in Alzheimer’s disease (AD). The production and deposition of Aβ are important factors affecting AD progression and prognosis. The deposition of neurotoxic Aβ contributes to damage of the blood–brain barrier. However, the BBB is also crucial in ma...
Main Authors: | Dong Wang, Fanglian Chen, Zhaoli Han, Zhenyu Yin, Xintong Ge, Ping Lei |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-07-01
|
Series: | Frontiers in Cellular Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fncel.2021.695479/full |
Similar Items
-
Therapeutic Potential of Direct Clearance of the Amyloid-β in Alzheimer’s Disease
by: Dong Eun Kim, et al.
Published: (2020-02-01) -
Changes of blood-brain-barrier function and transfer of amyloid beta in rats with collagen-induced arthritis
by: Po-Hsuan Lai, et al.
Published: (2021-01-01) -
Advanced Glycation End Products: Link between Diet and Ovulatory Dysfunction in PCOS?
by: Deepika Garg, et al.
Published: (2015-12-01) -
Pinocembrin protects against β-amyloid-induced toxicity in neurons through inhibiting receptor for advanced glycation end products (RAGE)-independent signaling pathways and regulating mitochondrion-mediated apoptosis
by: Liu Rui, et al.
Published: (2012-09-01) -
Synthetic Fragments of Receptor for Advanced Glycation End Products Bind Beta-Amyloid 1–40 and Protect Primary Brain Cells From Beta-Amyloid Toxicity
by: Anna V. Kamynina, et al.
Published: (2018-09-01)